Factors Associated with Adoption of Immune Checkpoint Inhibitor Treatment for Advanced Melanoma: A SEER-Medicare Cohort Study

• Main Authors: Cassandra Mohr (Author), Kaiping Liao (Author), Candice L. Hinkston (Author), Mackenzie R. Wehner (Author), Meng Li (Author)
• Formato: Livro
• Publicado em: Elsevier, 2024-07-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

We aimed to explore the differences in immune checkpoint inhibitor (ICI) immunotherapy utilization for advanced melanoma by examining patient and neighborhood characteristics. We performed a retrospective cohort study using a deidentified, random sample of SEER-Medicare beneficiaries aged ≥65 years...